

What is Buprenorphine/Naloxone (Suboxone)? Learn about its uses, dosage, cost, side effects, and everything you need to know in 2026.
Buprenorphine/Naloxone is a prescription combination medication used to treat opioid use disorder (OUD) by reducing cravings and withdrawal symptoms without producing the full euphoric effects of opioids.
If you or someone you know has been prescribed this medication — or you're just trying to understand what it is — this guide covers everything you need to know in 2026, including how it works, how it's taken, what it costs, and who should avoid it.
Buprenorphine/Naloxone is a combination of two drugs:
It's classified as a Schedule III controlled substance by the DEA, meaning it has accepted medical use but can still be misused.
Buprenorphine/Naloxone is available under several brand names:
Generic versions of sublingual films and tablets are also widely available, which are significantly less expensive than brand-name options.
The FDA first approved Buprenorphine/Naloxone (as Suboxone) in 2002 for the treatment of opioid dependence. It was one of the first medications that could be prescribed in a doctor's office for OUD, rather than requiring daily visits to a methadone clinic. As of 2023, the X-waiver requirement was removed, meaning any provider with a DEA license can now prescribe it.
Buprenorphine/Naloxone is FDA-approved for:
It is sometimes used off-label for chronic pain management (the Buprenorphine component) and in certain clinical settings for neonatal abstinence syndrome.
For a detailed look at how this medication works in your body, see our guide on how Buprenorphine/Naloxone works.
Buprenorphine/Naloxone comes in three forms:
Important instructions:
Induction (starting dose): 2mg/0.5mg to 8mg/2mg on Day 1. Your doctor will start you on a lower dose and increase it gradually.
Maintenance dose: 4mg/1mg to 24mg/6mg daily. The most common maintenance dose is 16mg/4mg per day.
Critical timing: You must wait at least 12 hours after your last opioid use before taking the first dose of Buprenorphine/Naloxone. Taking it too soon can trigger precipitated withdrawal, which causes intense withdrawal symptoms to come on suddenly.
Buprenorphine/Naloxone is not safe for everyone. You should not take it if you have:
Use with caution if you are pregnant, breastfeeding, have mild to moderate liver disease, or are over 65. It is not approved for patients under 16 years of age.
Always tell your doctor about all other medications you're taking. Buprenorphine/Naloxone has significant drug interactions, especially with benzodiazepines, alcohol, and other CNS depressants.
Cost varies significantly depending on whether you use brand-name or generic, your insurance, and your pharmacy:
Most commercial insurance plans and Medicaid cover generic Buprenorphine/Naloxone. Medicare Part D also covers it. However, prior authorization is commonly required, and some plans have quantity limits or step therapy requirements.
If cost is a barrier, several options can help:
For a complete breakdown of savings options, see our guide on how to save money on Buprenorphine/Naloxone.
Buprenorphine/Naloxone has been a game-changer for opioid use disorder treatment since its approval in 2002. It allows people to manage their recovery from a doctor's office or even through telehealth, without the daily clinic visits required by Methadone. With generic options now widely available and the X-waiver eliminated, access to this medication is better than ever in 2026.
If you have a prescription and need help finding it at a pharmacy, Medfinder can help you check stock near you. For information on side effects to watch for, see our dedicated guide.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.